Ad Header



The Pulse of the Pharmaceutical Industry

Pfizer receives subpoenas in U.S. intravenous saline solution probe

Written by: | | Dated: Wednesday, April 19th, 2017


Pfizer Inc said on Wednesday that the company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation focused on drugmakers that market intravenous saline solution.

Pfizer disclosed the subpoenas in a statement a day after ICU Medical Inc, which recently acquired the company’s global infusion therapy business, on Tuesday said it had received a similar subpoena related to intravenous solutions.


(Reporting by Nate Raymond in Boston)


Reuters source:

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2018 Focus: Top 10 Pipelines, Focused Value in Pharma, Agenda 2018 and MAHF!


Ad Right Bottom

Main Navigation